This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
Although effective smoking cessation interventions exist, information is limited about their cost-effectiveness and cost-utility.
To assess the cost-effectiveness and cost-utility of an Internet-based multiple computer-tailored smoking cessation program and tailored counseling by practice nurses working in Dutch general practices compared with an Internet-based multiple computer-tailored program only and care as usual.
The economic evaluation was embedded in a randomized controlled trial, for which 91 practice nurses recruited 414 eligible smokers. Smokers were randomized to receive multiple tailoring and counseling (n=163), multiple tailoring only (n=132), or usual care (n=119). Self-reported cost and quality of life were assessed during a 12-month follow-up period. Prolonged abstinence and 24-hour and 7-day point prevalence abstinence were assessed at 12-month follow-up. The trial-based economic evaluation was conducted from a societal perspective. Uncertainty was accounted for by bootstrapping (1000 times) and sensitivity analyses.
No significant differences were found between the intervention arms with regard to baseline characteristics or effects on abstinence, quality of life, and addiction level. However, participants in the multiple tailoring and counseling group reported significantly more annual health care–related costs than participants in the usual care group. Cost-effectiveness analysis, using prolonged abstinence as the outcome measure, showed that the mere multiple computer-tailored program had the highest probability of being cost-effective. Compared with usual care, in this group €5100 had to be paid for each additional abstinent participant. With regard to cost-utility analyses, using quality of life as the outcome measure, usual care was probably most efficient.
To our knowledge, this was the first study to determine the cost-effectiveness and cost-utility of an Internet-based smoking cessation program with and without counseling by a practice nurse. Although the Internet-based multiple computer-tailored program seemed to be the most cost-effective treatment, the cost-utility was probably highest for care as usual. However, to ease the interpretation of cost-effectiveness results, future research should aim at identifying an acceptable cutoff point for the willingness to pay per abstinent participant.
Smoking is the single most preventable cause of illness and premature death in the world and is an important risk factor for 6 of the 8 leading causes of death, including several types of cancer, cardiovascular diseases, and respiratory diseases [
Extensive evidence exists on the clinical effectiveness of behavioral interventions for smoking cessation [
Despite the proven clinical effectiveness of behavioral smoking cessation interventions, information about their relative cost-effectiveness is limited. Previously, several cost-effective smoking cessation interventions have been developed [
Therefore, the objective of the present study was to compare the cost-effectiveness and cost-utility of (1) an Internet-based multiple computer-tailored smoking cessation program combined with a single tailored counseling session by a practice nurses, (2) only an Internet-based multiple computer-tailored smoking cessation program, and (3) care as usual, defined as practice nurses’ standard care regarding smoking cessation.
Economic evaluation studies aim to determine the costs and effects associated with an intervention and to compare these with the costs and effects of other interventions and/or current practice [
Based on a chosen perspective (eg, the health care perspective, health insurer perspective, or societal perspective), relevant costs and effects are identified.
Costs can be assessed prospectively by means of cost diaries, or retrospectively using cost questionnaires. Effects are usually assessed in terms of quality of life.
Health care and patient costs are usually valued in a monetary currency using manuals for cost analysis in health care research. Effects on quality of life are usually valued in QALYs gained or lost.
When comparing two interventions, an incremental cost-effectiveness ratio (ICER) can be calculated: ICER=(Ci–Cc)/(Ei–Ec). When comparing more than 2 interventions, a net monetary benefit (NMB) should be calculated using the willingness to pay (WTP): NMB=(Ei–Ec)×WTP–(Ci–Cc). A description of both formulas can be found in
To deal with the sampling uncertainty bootstrap analyses can be used, whereas a sensitivity analysis can be conducted to deal with uncertainty due to the assumptions made.
The present economic evaluation study was trial-based, embedded in a randomized controlled trial (RCT) that tested the effectiveness of an Internet-based multiple computer-tailored smoking cessation program and tailoring counseling by practice nurses. This 3-armed RCT was conducted among Dutch adult smokers and had a follow-up period of 12 months. From May 2009 to June 2010, 91 practice nurses working in different Dutch general practices throughout the Netherlands recruited smoking patients for participation in the RCT. To aid recruitment, several recruitment materials were provided (eg, desk displays, posters, and business cards). Smokers interested in participation could sign up for the study on the study website. There, information was provided about the objectives of the study, the randomization procedure, and the incentive provided when respondents completed all questionnaires (ie, a €10 gift voucher). When signing up, participants were able to choose their own username and password and were informed that no one but the research team would be able to retrieve these passwords. After providing informed consent, participants were randomized into 1 of the 2 intervention groups (multiple tailoring and counseling or multiple tailoring only) or into the usual care control group. Randomization took place at the participant level by means of a computer software randomization device.
The trial design was approved by the Medical Ethics Committee of Maastricht University and the University Hospital Maastricht (MEC 08-3-037; NL22692.068.08), and is registered with the Dutch Trial Register (NTR1351). A more detailed description of the study design has been published elsewhere [
Participants were eligible for participation if they smoked, were motivated to quit within 6 months, were 18 years or older, and were able to read and understand Dutch sufficiently to read study materials and participate in the trial. Moreover, they had to have access to the Internet. This resulted in a total of 414 eligible smokers.
The Internet-based multiple computer-tailored smoking cessation program was based on a previously developed single computer-tailored intervention [
After receiving the first tailored feedback, participants in the multiple tailoring and counseling group were prompted to schedule a counseling meeting with their practice nurse within 6 to 8 weeks. They received this counseling session instead of the third tailored feedback letter at the 6-week follow-up. A counseling protocol was provided to assist practice nurses in guiding these counseling sessions. This protocol consisted of 3 chapters guiding on 3 different types of participants: smokers who had quit successfully, smokers who had quit but relapsed, and smokers who had not yet quit. The content of the counseling session was developed to be as similar as possible to the content of the computer-tailored feedback and was also tailored to the participant characteristics mentioned previously. After 6 months, practice nurses were instructed to call their patients to ask them about their progress toward permanent cessation and, if needed, to provide them with additional cessation support.
Participants randomized in the usual care group received smoking cessation guidance according to participating practice nurses’ standard practice, which can vary from a brief intervention consisting of a single recommendation to stop smoking to more intensive interventions [
Overview of the intervention elements received by the 3 groups.
Self-reported online questionnaires were used to assess both costs and effects. Questionnaires were administered at baseline and at 6-week, 6-month, and 12-month follow-ups. When follow-up questionnaires were not completed by 1 week after the invitation, an email reminder was sent. At 12-month follow-up, this email reminder was followed by a phone call to collect data.
The present economic evaluation study was conducted from a societal perspective. This implies that intervention costs, health care costs, and patient costs were identified as relevant. Intervention costs consisted of all costs that could be attributed to the delivery of the intervention, such as hosting costs for the Internet-based program and costs associated with counseling sessions. Costs for the development of the intervention and research-specific costs were excluded because these costs are sunk costs, costs that would already be spent before the intervention is implemented. In total, intervention costs were €57.70 per participant in the multiple tailoring and counseling group and €7.70 per participant in the multiple tailoring group. Interventions costs in the usual care group were considered zero because no intervention materials needed to be developed for this group. Health care costs related to general practitioners’ or practice nurses’ (telephone) consultations or home visits (other than the counseling session which was part of the multiple tailoring and counseling intervention), inpatient and outpatient specialist care, alternative medicine, mental health care, prescribed and over-the-counter (OTC) smoking cessation medication, hospital admissions, smoking cessation aids, and other care (eg, paramedics consultations or professional home care). Patient costs consisted of traveling and time lost due to participation in the intervention. However, for primary and secondary analyses, patient costs were not valued in monetary costs, but considered as reflected in participants’ reported quality of life [
Self-reported health care use was assessed during a 12-month follow-up period using a 3-month retrospective costing questionnaire that consisted of open-ended questions. Participants indicated whether they had received each type of care during the past 3 months, and if so, how often. The time participants spent using the online tailoring program was tracked by computer-registered log-in and log-out data. To assess time spent on counseling, we used a mean time of 20 minutes for face-to-face counseling sessions and an average of 10 minutes for telephone consultations. Traveling time was measured based on average travel distances to a general practitioner in the Netherlands [
To valuate health care usage and patient costs, the updated Dutch manual for cost analysis in health care research was used [
The primary outcome measure used in the cost-effectiveness analysis (CEA) was prolonged abstinence measured at 12-month follow-up. This was assessed by 1 item asking whether the participant had refrained from smoking since the previous measurement at 6-month follow-up (ie, abstinence for at least 6 months; 1=no, 2=yes). Secondary outcome measures were 7-day point prevalence abstinence assessed by 1 item asking whether the participant had refrained from smoking during the past 7 days (1=no, 2=yes) and addiction level measured by the abbreviated Fagerström Test for Nicotine Dependence (FTND; 0=not addicted, 10=highly addicted) [
The primary outcomes measure for the cost-utility analysis (CUA) was quality of life, measured in terms of QALYs. The valuation of effects on quality of life implies that utility scores need to be computed. In the present study, utilities were measured by the EuroQol EQ-5D [
All analyses were conducted according to the intention-to-treat principle. Missing data for costs, EQ-5D items, overall tobacco consumption, and addiction level were replaced by mean imputation by using participants’ scores on the previous and next measurement. When mean imputation was not possible because of missing data on multiple measurement points, missing data were replaced using the last observation carried forward (preferred choice) or next observation carried backward method. Missing data for smoking abstinence were replaced using a negative scenario; participants lost to follow-up were considered still smoking.
To investigate the comparability of the 3 groups with regard to demographics, baseline values of outcomes, and health care–related costs over the past 3 months, 1-way analyses of variance (ANOVA) with Tukey post hoc tests and chi-square tests were conducted. To determine whether selective dropout had occurred, a comparison was made between those lost to follow-up and those who remained in the study after 12 months using 2-sided
The 3 groups were compared with regard to their mean annual costs using nonparametric bootstrapping (5000 times) with 95% confidence intervals in percentiles [
First, incremental costs and effects were calculated for each of the 3 treatments studied. Subsequently, an incremental cost-effectiveness ratio (ICER) was calculated to compare costs and effects between pairs of study groups according to the following formula: ICER=(Ci–Cc)/(Ei–Ec). In this formula,
Sampling uncertainty around the estimates of cost-effectiveness and cost-utility was taken into account by using nonparametric bootstrap resampling techniques [
To deal with the uncertainty of parameter estimates from the primary analyses, a sensitivity analysis was conducted. As described earlier, in primary analyses patient costs (ie, traveling and time costs) were not valued in monetary costs but considered as reflected in participants’ reported quality of life [
Bootstrap analyses were conducted using Microsoft Office Excel 2003. All other analyses were conducted using SPSS 17.0 (SPSS Inc, Chicago, IL, USA).
Of the 414 participants who were eligible for participation, 163 were randomized into the multiple tailoring and counseling group, 132 into the multiple tailoring group, and 119 into the usual care group. No baseline differences were found between the 3 groups (
A significant difference was found between the multiple tailoring and counseling and the usual care groups with regard to annual health care–related costs per patient, with significantly higher costs in the multiple tailoring and counseling group (
Comparability of the 3 groups, multiple tailoring and counseling (MTC), multiple tailoring (MT), and usual care (UC), regarding demographics, baseline values of outcomes, and health care–related costs over the past 3 months (N=414).
Variable | MTC |
MT |
UC |
|
χ2 (df) |
|
|
Age, mean (SD) | 48.1 (12.0) | 47.8 (12.5) | 48.1 (11.3) | 0.03 (2,406) |
|
.97 | |
Male, n (%) | 60 (36.8) | 41.2 (54) | 42.9 (51) |
|
1.2 (2) | .56 | |
|
|
|
|
|
1.9 (2) | .76 | |
|
High | 39 (23.9) | 30 (22.9) | 24 (20.2) |
|
|
|
|
Medium | 68 (41.7) | 63 (48.1) | 56 (47.1) |
|
|
|
|
Low | 56 (34.4) | 38 (29.0) | 39 (32.8) |
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular diseases, n (%) | 27 (16.6) | 17 (13.0) | 18 (15.1) |
|
0.7 (2) | .69 |
|
Respiratory diseases, n (%) | 38 (23.3) | 44 (33.6) | 36 (30.3) |
|
4.0 (2) | .14 |
|
Diabetes, n (%) | 8 (4.9) | 6 (4.6) | 7 (5.9) |
|
0.2 (2) | .89 |
|
Cancer, n (%) | 10 (6.1) | 12 (9.2) | 8 (6.7) |
|
1.1 (2) | .59 |
Cigarettes smoked per day, mean (SD) | 20.6 (10.3) | 23.5 (23.2) | 21.5 (15.5) | 1.14 (2,411) |
|
.32 | |
FTNDa score (range 0-10), mean (SD) | 5.3 (2.2) | 5.6 (2.0) | 5.3 (2.1) | 0.94 (2,406) |
|
.39 | |
Utility, mean (SD)b | 0.8 (0.2) | 0.8 (0.2) | 0.8 (0.2) | 0.60 (2,375) |
|
.55 | |
|
425.9 (1506.9) | 286.9 (436.6) | 236.9 (474.0) | 1.19 (2,369) |
|
.31 | |
|
General practitioner | 53.2 (50.2) | 61.0 (73.2) | 49.7 (55.1) | 1.11 (2,380) |
|
.33 |
|
Medical specialist | 65.4 (132.1) | 78.6 (170.9) | 87.6 (202.8) | 0.57 (2,373) |
|
.57 |
|
Hospital | 206.9 (1371.3) | 50.9 (205.2) | 47.9 (230.8) | 1.47 (2,378) |
|
.23 |
|
Alternative healer | 5.1 (25.1) | 9.4 (41.6) | 4.9 (24.2) | 0.84 (2,379) |
|
.44 |
|
Mental health care | 30.3 (133.5) | 24.3 (100.8) | 38.2 (186.5) | 0.27 (2,380) |
|
.76 |
|
Prescribed and OTC medication | 26.7 (78.8) | 36.4 (95.5) | 13.6 (58.4) | 2.37 (2,381) |
|
.10 |
|
Medical aids and assistive devices | 1.7 (4.1) | 3.4 (12.6) | 1.9 (4.8) | 1.73 (2,380) |
|
.18 |
|
Other care | 26.0 (268.3) | 19.2 (166.4) | 12.5 (65.7) | 0.15 (2,379) |
|
.86 |
a Fagerström Test for Nicotine Dependence (0=not addicted, 10=highly addicted)
b Based on the Dutch algorithm for the EQ-5D scores.
c Costs for prior 3 months.
Mean annual costsa per participant in the MTC, MT, and UC groups.
Cost type | Costs per group (€) |
95% CIb | |||||||
|
MTC | MT | UC | MTC–MT |
|
UC–MT | MTC–UC | ||
|
|
|
|
|
|
|
|||
|
Intervention costs (n=384) | 57.70 | 7.70 | 0 |
|
|
|
||
|
|
|
|
|
|
|
|||
|
General practitioner (n=384) | 157 (14) | 180 (27) | 139 (17) | –86.1 to 32.3 | –105.8 to 15.5 | –25.4 to 61.4 | ||
|
Medical specialist (n=374) | 298 (52) | 251 (62) | 224 (48) | –115.8 to 198.1 | –188.3 to 116.6 | –61.2 to 213.8 | ||
|
Hospital (n=380) | 610 (288) | 267 (106) | 172 (84) | –139.7 to 1054.7 | –374.0 to 161.1 | –17.0 to 1133.4 | ||
|
Alternative healer (n=382) | 17 (6) | 29 (13) | 18 (9) | –42.9 to 13.7 | –43.1 to 18.6 | –23.4 to 18.8 | ||
|
Mental health care (n=384) | 106 (39) | 95 (34) | 131 (71) | –92.2 to 109.8 | –97.1 to 209.4 | –200.2 to 111.9 | ||
|
Prescribed and OTC smoking cessation medication (n=384) | 148 (24) | 144 (30) | 90 (23) | –72.7 to 79.1 | –129.6 to 18.5 | –9.0 to 124.6 | ||
|
Smoking cessation aids (n=384) | 20 (10) | 15 (10) | 19 (14) | –21.6 to 32.5 | –27.9 to 41.0 | –34.4 to 32.3 | ||
|
Other care (n=382) | 122 (87) | 21 (12) | 41 (22) | –15.9 to 293.6 | –24.7 to 72.4 | –45.9 to 281.7 | ||
|
Overall health care–related costs (n=370) | 1564 (338) | 1016 (158) | 761 (122) | –95.4 to 1381.4 | –642.2 to 139.1 | 194.3-1611.8 |
a Volumes and price details are available upon request.
b Based on 5000 bootstrap replications.
Mean annual effect on smoking abstinence, QALY, and addiction level in the MTC, MT, and UC groups.
Effects | MTC | MT | UC |
|
χ2 (df) |
|
Prolonged abstinent (n=414), n (%) | 14 (8.6) | 20 (15.2) | 12 (10.1) |
|
3.4 (2) | .19 |
QALY (EQ-5D)a (n=384), mean (SD) | 0.86 (0.15) | 0.83 (0.21) | 0.84 (0.21) | 0.89 (2,381) |
|
.41 |
7 days abstinent (n=414), n (%) | 20 (12.3) | 27 (20.5) | 15 (12.6) |
|
4.6 (2) | .10 |
FTNDb score (n=409), mean (SD) | 4.76 (2.41) | 5.21 (2.30) | 4.81 (2.46) | 1.40 (2,406) |
|
.25 |
a Based on the Dutch algorithm for the EQ-5D scores.
b Fagerström Test for Nicotine Dependence (0=not addicted, 10=highly addicted); reversed range.
Incremental costs and effects per abstinent smoker and per QALY gained for the MTC, MT, and UC groups with a willingness-to-pay threshold of €18,000.
Intervention | Incremental costs (€) | Incremental probabilitya | Incremental costsb (€) | |
|
|
|
|
|
|
UC |
|
|
|
|
MT vs UC | 255 | .05 | 5100 |
|
MTC vs UC | 806 | –.02 | Dominatedd |
|
MTC vs MT | 551 | –.07 | Dominatede |
|
|
|
|
|
|
UC |
|
|
|
|
MT vs UC | 255 | –.01 | Dominatedg |
|
MTC vs UC | 806 | .02 | 40,300 |
|
MTC vs MT | 551 | .03 | 18,367 |
a Probability of being abstinent/gaining 1 QALY.
b Per abstinent participant or per QALY; calculated according to the formula ICER/ICUR=(Ci–Cc)/(Ei–Ec); additional information available in
c Coded as 1=not abstinent and 2=abstinent.
d ICER=–40.300.
e ICER=–7.871.
f Based on the Dutch algorithm for the EQ-5D scores.
g ICUR=–25.500.
The CEA showed that until a threshold value for the WTP of €5100 per abstinent participant, usual care was probably the most efficient treatment. However, from a WTP of €5100 or higher, multiple tailoring was probably most cost-effective (
Results from secondary analyses showed that with 7-day point prevalence abstinence, a high probability was found (ie, 88%, with a WTP of €18,000 per abstinent participant) that multiple tailoring was the most cost-effective treatment. Regarding the level of addiction, however, it was most probable that multiple tailoring would be least efficient (
With regard to QALYs gained,
With a WTP of €18,000 per abstinent participant, the CUA showed that usual care would probably (ie, 64%) be the most efficient treatment (
Results from cost-effectiveness and cost-utility analyses based on 1000 bootstrap replications.
Type of analysis | Group, n | Probability of highest net monetary benefita, % | |||||
|
MTC | MT | UC | MTC | MT | UC | |
|
|
|
|
|
|
|
|
|
Prolonged abstinencef | 145 | 121 | 104 | 0 | 78 | 21 |
|
QALY (EQ-5D)b | 145 | 121 | 104 | 18 | 18 | 64 |
|
|
|
|
|
|
|
|
|
7-day ppac,f | 145 | 121 | 104 | 1 | 88 | 11 |
|
FTND scored | 135 | 115 | 96 | 50 | 6 | 45 |
|
|
|
|
|
|
|
|
|
Prolonged abstinencef | 145 | 121 | 104 | 1 | 76 | 24 |
|
QALY (EQ-5D)b | 145 | 121 | 104 | 19 | 15 | 66 |
aWith a willingness-to-pay threshold of €18,000.
bBased on the Dutch algorithm for the EQ-5D scores.
cppa: point prevalence abstinence.
dFTND: Fagerström Test for Nicotine Dependence (0=not addicted, 10=highly addicted).
eIncrease in program costs from €57.70 to €141.89 (MTC group) and from €7.70 to €82.24 (MT group) caused by the inclusion of patient costs.
fCoded as 1=not abstinent and 2=abstinent.
Cost-effectiveness acceptability curve for the 3 treatments studied: MTC, MT, and UC.
Cost-utility acceptability curve for the 3 treatments studied: MTC, MT, and UC.
To our current knowledge, this was the first study to determine the cost-effectiveness and cost-utility of a behavioral smoking cessation intervention consisting of Internet-based computer tailoring with and without counseling by a practice nurse. The results presented suggest that participants who received the Internet-based multiple computer-tailored program and tailored counseling by their practice nurse reported significantly more annual health care-related costs than participants who received care as usual. A potential explanation for this finding might be that smokers were prompted by the tailored feedback they received to ask for more smoking cessation guidance, eg, additional counseling sessions with the practice nurse or a prescription for smoking cessation medication. Although participants who received the Internet-based program only might have had the same tendency, the practice nurses for participants in the multiple tailoring and counseling group might have been prompted by their patients’ visit to offer them more smoking cessation help. Because the current smoking cessation guidelines in the Netherlands recommend more than 1 counseling session [
Furthermore, the present study showed that the Internet-based multiple computer-tailored smoking cessation program would probably be the most cost-effective of the 3 treatments under study. Although no similar studies yet exist within the field of smoking cessation, this finding is in-line with findings from recent studies toward the cost-effectiveness of Internet-based interventions aimed at other health-related behaviors or health problems [
Regarding cost-utilities, the results suggest that care as usual would probably be the most preferable of the treatments studied. A potential explanation for this finding might be that the follow-up period of 12 months was not sufficiently long for the beneficial effects of the intervention on smoking abstinence to be translated into detectable changes in quality of life, as recent ex-smokers are known to suffer from withdrawal symptoms [
The present study aimed to contribute to the literature by examining the cost-effectiveness and cost-utility of an Internet-based smoking cessation intervention, something that has not been done before to our knowledge. In the present study, in addition to generic quality of life, disease-specific effects of the intervention (ie, smoking abstinence) were taken into account. To facilitate the comparison of the cost-effectiveness of interventions targeting different diseases, effects are usually assessed in terms of quality of life. However, to compare smoking cessation interventions more specifically, disease-specific effect measures might be more informative.
Nevertheless, the present study also had its limitations. First, it suffered from relatively high dropout rates. High rates of attrition seem to be inherent to many Internet-based interventions and dropout rates of 44% are not uncommon [
The Internet-based multiple computer-tailored program seemed to be the most cost-effective treatment when smoking abstinence was the outcome measure. However, the cost-utility, using quality of life as the outcome measure, was probably the highest with care as usual. To enable the interpretation of the incremental costs per abstinent participant found in the cost-effectiveness analyses, future research should aim at identifying an acceptable cutoff point for the WTP per abstinent participant.
Economic evaluation studies in a nutshell.
A tailored smoking cessation advice for a respondent who reported to still be smoking at six-month follow-up and whose self-efficacy to quit has decreased since baseline.
CONSORT-EHEALTH checklist V1.6.2 [
cost-effectiveness analysis
cost-utility analysis
cost-effectiveness acceptability curve
cost-utility acceptability curve
Fagerström Test for Nicotine Dependence
incremental cost-effectiveness ratio
I-Change Model
incremental cost-utility ratio
multiple tailoring and counseling
multiple tailoring
net monetary benefit
over-the-counter
quality-adjusted life year
randomized controlled trial
usual care
willingness to pay
The study was funded by the Dutch Cancer Society (UM 2007-3834). We would like to thank Thea van Asselt for the additional assistance in conducting the cost-effectiveness and cost-utility analyses.
Hein de Vries is scientific director of Vision2Health, a company that licenses evidence-based innovative computer-tailored health communication tools.